News Focus
News Focus
Followers 9
Posts 1217
Boards Moderated 0
Alias Born 03/13/2013

Re: Biobillionair post# 5133

Friday, 04/26/2013 12:41:59 AM

Friday, April 26, 2013 12:41:59 AM

Post# of 447261
Agreed, the generic would also need to be able to :

(i)source the supply of API at a time where Amarin has cornered the market;and
(ii) manufacture a bio equivalent product which will not be easy with a product like this.

Finally, the margins on this are not stellar compared to most drugs so the risk / reward may not stack up for a generic company.

..........and don't forget the statin/ vascepa combo product 3/4 years down the line.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News